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httcense.Abstract Objective: To test the hypothesis that hemodynamic and metabolic characteristics of
intracranial neoplasms detected with magnetic resonance spectroscopy and perfusion weighted
imaging are efﬁcient predictors of tumor response to radiosurgery.
Methods: Fifty-four patients with 59 intracranial neoplasms, who underwent evaluation with echo-
planar PW and MRS imaging prior to gamma knife radiosurgery were selected for this retrospective
analysis. The mean irradiation dose was 13.76 Gy. The mean follow up after GNR constituted
24 months. Predictive diagnostic accuracy was calculated with standard formulas. The association
of tumor response to radiosurgery with pretherapeutic MRI parameters was estimated using the
Mann–Whitney U test.
Results: Signiﬁcant association was found between the perfusion and hemodynamic parameters of
intracranial neoplasms and the outcome of GKR. Diagnostic accuracy of multimodel MRI was
89% among low grade and 65% among high grade neoplasms. The overall accuracy was 81%.
Normalized rCBV, choline, NAA and lipid contents and Chol/cr and NAA/cr were statistically
different between low and high grade neoplasms (p< 0.001).ife radiosurgery; MRI, magnetic resonance imaging; PMS, proton magnetic resonance spectroscopy,
morphic xanthoastrocytoma
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Radiosurgery has been especially helpful for the localized, high
precise treatment of brain tumors. Due to the steep fall of the
irradiation ﬁeld (isodose) from the center of the target to be
ablated, normal structures such as brain tissue and other vas-
cular and neural structures around it are relatively spared. This
is achieved through the high mechanical precision of the radi-
ation source and the assured reproducibility of the target (1).
General indications for radiosurgery include many kinds of
brain tumors such as meningiomas, schwannomas, germino-
mas, pituitary adenomas, metastatic brain tumors, malignant
gliomas and other neurological diseases as an alternative meth-
od in place of surgical resection (1–7) It is frequently used to
treat tumors that are not amenable to complete surgical re-
moval or in patients with smaller metastatic brain tumors (7).
Signiﬁcant clinical judgment must be used with this tech-
nique and consideration must include lesion type, size, loca-
tion, pathology if available and age and general health of the
patient. General contraindications include an excessively large
size of the target lesion or lesions too numerous for practical
treatment. The non interference with the quality of life of the
patient in the postoperative period competes with the inconve-
nience of the latency of months until the results of radiosur-
gery are accomplished. Outcome may not be evident for
months after the treatment. Since radiosurgery does not re-
move the tumor but results in a biological inactivation of the
tumor, lack of growth of the lesion is normally indicative of
treatment success (6,7).
Although conventionalMRI is, undoubtedly, themost sensi-
tive modality available for the detection of brain tumors, its
speciﬁcity is low. Reported values for accurate grading of glio-
mas in conventional MRI varies from 55% to 83.3%
(3,5,14).One of the risks of incorrect grading is inappropriate
therapy which may be unacceptable when invasive treatments
or radio- or chemotherapy are performed. It is also limited in
the assessment of tumor extensionwhich potentially affects ther-
apeutic decision making (8). Greater accuracy in imaging evalu-
ation is particularly important when lesions cannot be treated
surgically or when they occur at sites of high risk for biopsy.
In this regard it should also be noted that biopsy only provides
information about a portion of the neoplasm and not necessarily
about the whole of it. A more accurate noninvasive approach,
implies extending the attainable information beyond the mere
morphological parameters of contrast enhancement and vaso-
genic edema observed on conventional imaging (3).
Technological developments in MR imaging have led to the
availability of new techniques for the characterization of CNS
tumors. Perfusion weighted imaging (PWI) and MR spectros-
copy (MRS), for example, are relatively recent techniques that
combine morphological and structural information with phys-
iological and biochemical data. These techniques have recentlybeen used for the differentiation of cerebral neoplasms and
assessment of glial neoplasm, particularly in deﬁning their his-
tological grade (4,5). The high temporal resolution of modern
high-ﬁeld MR scanners (1.5 T and above) permits conven-
tional MR imaging to be combined with PWI and MRS se-
quences during the same procedure (3).
There are several recent reports that the metabolic and
hemodynamic characteristics of primary brain tumors pro-
vided by MR spectroscopic and perfusion imaging may be pre-
dictive of their response to chemotherapy and irradiation
(9,10). It was also shown that the metabolic proﬁle of meta-
static brain tumors is associated with several clinical predictors
of the local tumor control after whole brain radiation therapy
or stereotactic radiosurgery (10,11). Therefore it is possible to
speculate that the metabolic and hemodynamic parameters of
brain tumors can be by themselves predictive of tumor re-
sponse to irradiation. Evaluation of such associations consti-
tuted the objective of the present study.
2. Materials and methods
This study included a total of 56 patients with 64 intracranial
neoplasms, who had been referred to Gamma knife center at
Nasser institute between November 2004 and June 2009, and
underwent a combined multimodel imaging protocol compris-
ing conventional MR imaging, PWI and MRS at Misr Radiol-
ogy center prior to radiosurgery. Written informed consents
were obtained from all patients before the study. These pa-
tients were followed up for at least 2 years (24 ± 4 months)
following stereotactic radiosurgery both clinically and by con-
ventional MRI.
2.1. Clinical data
There were 25 men and 31 women; with age ranges from 3 to
77 (mean 52). The presenting complaints varied according to
the tumor location and were related in the majority of cases
to increased intracranial tension. Patients presented with head-
ache, seizures, ataxia, vertigo, facial nerve palsy, numbness or
neuralgia, gradual hearing loss, ptosis and visual disturbances.
Occlusive hydrocephalus was found in 9 cases (28%) which
was relieved by ventriculoperitoneal shunts implanted in 8
cases and ventriculostomy done in a solitary case prior to radi-
osurgery. The histopathological diagnosis was available in
only 2 cases as most of the lesions were located at sites of high
risk for biopsy (eloquent areas of the brain).
2.2. Magnetic resonance images (MRI)
MRI studies were obtained in all cases before treatment with a
1.5 T superconducting system, the Gyroscan Intera 1.5T (Phi-
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head coil. The MR imaging protocol consisted of pre- and
post-contrast axial and sagittal T1-weighted imaging (TR/
TE: 500/10), axial and coronal T2-weighted imaging (TR/
TE: 2200/70), and axial ﬂuid attenuated inversion recovery
(FLAIR) imaging (TR/TI/TE: 11000/2800/125). The conven-
tional images demonstrated the morphology of the tumor, its
location and its anatomical relationships.
2.3. Perfusion-weighted imaging
PWI involved acquisition of an EPI GE sequence with the fol-
lowing parameters: slice thickness 6 mm, spacing 1 mm, TR
2,000 ms, TE minimum, single shot, matrix 128 · 128, FOV
30 · 22 cm, NEX 1, number of slices 10. The interslice gap var-
ied between 1 and 3 mm, depending on the extension of the le-
sion on conventional MR imaging. Imaging was performed
with a standard 0.1 mmol/kg body weight dose of Gd-DTPA,
administered through a catheter in the antecubital vein by
means of an automatic power injector (Medrad, Pittsburgh,
Pa.) at a rate of 3 ml/s followed by a bolus injection of isotonic
saline at the same rate. Acquired images were transferred to a
dedicated workstation (Extended MR workspace 2.6.32, 2009,
CG, Philips medical system Nederland BV Veenpluis 4.6 5684
PC best The Netherland) for post processing. From the time
course images the change in tissue T2* relaxation rate
(DR2*) was calculated. This parameter is proportional to the
tissue concentration of the contrast agent. Then relative cere-
bral blood volume (rCBV) maps were calculated, pixel by pix-
el, by numerically integrating the area under the tissue
concentration curves (AUC). A gamma-variate function was
applied to the calculated DR2* curve to approximate the curve
that would have been obtained in the absence of recirculation
or leakage. For each PWI data set, regions of interest (ROIs)
were placed in the areas of maximal abnormality as visually
determined from rCBV. Among patients the ROI size ranged
from 110 mm2 (20pixels) and 440 mms2 (80 pixels). For each
lesion ROI measurements were also acquired from a ROI of
identical size positioned on the contralateral homologous nor-
mal-appearing white matter for a lesion in the white matter
and on the contralateral normal gray matter for a lesion in
the gray matter and the CBV ratio was calculated.
2.4. MR spectroscopy
Proton MR spectroscopic imaging was done with multivoxel
Chemical shift imaging using a single voxel point-resolved
spin-echo sequence (PRESS) for localization and volume pre-
selection. Water suppression was done with three-pulse chem-
ical-shift selective saturation sequence (CHESS) with a RF
pulse of bandwidths of 1100 Hz for the 180 pulse and
2000 Hz for the 90 pulse. Single voxel was acquired using short
and intermediate echo times to make the initial diagnosis.
Multivoxel imaging was done using long echo time to further
characterize different regions of the mass, and to assess brain
parenchyma around or adjacent to the mass as well as the con-
tralateral homologous area of the healthy brain, with the pa-
tient serving as his or her own control. With a short TE of
30 ms, metabolites with both short and long T2 relaxation
times are observed and the signal-to-noise ratio is high. An
intermediate TE of 144 ms was used because it inverts lactateat 1.3 ppm. With a long TE of 288 ms in multivoxel imaging,
only metabolites with a long T2 are seen, producing a spec-
trum with primarily NAA, creatine, and choline. For each pa-
tient, the volumes of interest (VOI) of all samples were
identical, variable for each case from 20 · 20 · 10 mm to
20 · 20 · 20 mm depending on the lesion volume. At least
one VOI for each lesion was centered in the area of the maxi-
mum rCBV obtained in the tumor tissue.
Data processing was performed on the same Workstation
as of perfusion MRI.
The metabolite peaks were assigned as follows: Myoinositol
3.6 ppm, Cho, 3.22 ppm; Cr, 3.02 ppm; NAA, 2.02 ppm; mo-
bile lipids, 0.5–1.5 ppm. Lactate was identiﬁed at 1.33 ppm
by its characteristic doublet at TE of 144 ms. Normalized:
NAA, Cho, total creatine and lipids, expressed in arbitrary
units, were obtained by dividing their values from within tu-
mor regions to the mean value of normal tissue total creatine,
which serves as the internal standard in these patients as it is
relatively constant throughout the normal human brain. Since
tumors are commonly heterogeneous, with necrotic cores, pro-
liferative rims and invasion of surrounding brain tissue, the
voxel with the maximum Cho signal has been chosen for anal-
ysis. Metabolite ratios were obtained by a neuroradiologist
blinded to the perfusion and conventional MR imaging data.
Maximal Cho/Cr and minimum NAA/Cr ratios were obtained
from spectral maps. To ensure quality control and acceptable
quality of spectroscopic data, normalized values for Cho/Cr
and NAA/Cr were obtained in normal-appearing white matter
in the contralateral hemisphere.
2.4.1. Tumor grading by MR perfusion weighted and
spectroscopic imaging
In our study a rCBV threshold value of 1.75 was used in dis-
criminating low from high grade neoplasms. Values for
Chol/Cr >1.5, and NAA/Cr <1.6 were considered for dis-
criminating low from high grade tumors. Tumors with signiﬁ-
cantly high levels of choline, and lipids/lactate were assigned as
high grade tumors. Low myoinositol/Cr ratios were also asso-
ciated with high grade tumors although not estimated in all
cases. The normalized maximum rCBV values, the maximum
Cho/Cr and minimum NAA/Cr ratios in tumor, among all
samples, were selected to categorize low and high grade tu-
mors. If NAA and Cho peaks could not be differentiated from
the spectrum’s electronic noise, a value of zero was assigned to
them, and therefore to their ratios.
2.5. Stereotactic radio surgery
SRS was done using the Leksell Gamma Knife model-C
(Elekta Instruments AB, Stockholm, Sweden). On the day
of treatment the stereotactic frame was ﬁxed under local
anesthesia. The axial slices of the contrast-enhanced double
dose gadolinium MRI were obtained through slices each
of 1.6 mm. Treatment planning and dose calculation were
performed using the Leksell GammaPlan software. In each case
all identiﬁed intracranial tumors were treated. The target vol-
ume was deﬁned as the area of contrast enhancement, without
inclusion of the surrounding brain tissue. The treatment
parameters for the tumor, investigated with proton MRS were
as follows: mean dose of 13.76 Gy (11–25 Gy), energy delivered
to tumor was from 51.1 to 217.0 mJ (mean: 131.8 ± 42.2 mJ;
86 R.H. Bassiouny et al.median: 131.0 mJ). In the vast majority of cases the marginal
dose corresponded to the 50% prescription isodose line.
2.6. Follow up
Patients were followed up with regular visits to the outpatient
clinic at 3 month intervals after treatment for reported high
grade tumors and at six month intervals for low grade tumors
up to at least 24 months. Control MRI was performed at the
time of each visit. Tumor size was estimated by a measurement
of the enhancing mass on the baseline and the follow-up exam-
inations. The largest cross sectional area was calculated by
multiplying the greatest cross-sectional dimension by the great-
est dimension perpendicular to it (and not by the summation
of tumor areas from all imaging slices).
Good response to radiosurgery was determined on the basis
of: (1) clinical neurological stability (2) Stationary size of the
mass, size shrinkage or an increase <25% in the sum of the
products of the maximum perpendicular dimensions of all
measurable lesions (3) central loss of enhancement in solid
lesions or loss of enhancement of known residual tumors on
follow-up postoperative conventional MR imaging (4) no
evidence of progression in any lesion and no new lesions.
Unfavorable response or progression was deﬁned as increase
of the original size (>25% in the sum of the products of the
maximum perpendicular dimensions of all measurable lesions),
tumor enlargement after initial regression, local recurrence or
development of new lesions.
2.7. Statistics
According to combined MRI criteria, lesions were classiﬁed
into 2 groups: group A including low grade tumors (typi-
cally benign and WHO I &II) and group B including high
grade malignant tumors (WHO III or IV). For group A le-
sions: those showing good response to radiosurgery with a
total control within 2 years were considered true negative,
and those showing progression were considered as false neg-
ative. For group B lesions: those showing a good local con-
trol with clinical stability and a local recurrence free survival
for up to 2 years were considered false positive, whereas
those showing progression were considered true positive.
Predictive diagnostic accuracy for each group was calculated
with standard formulas. The nonparametric Mann–Whitney
U test was used to compare the high grade (true positive)
and the low-grade (true negative) tumors, with respect to
median values of normalized rCBV, the Cho, NAA and lipid
contents as well as the normalized maximum Chol/Cr and
minimum NAA/Cr. The level of signiﬁcance was determined
at P< 0.05.
3. Results
The investigated lesions initially included 64 intracranial
neoplasms in 56 patients: 50 single and 14 multiple tumors.
5 lesions in 2 patients were excluded from the ﬁnal results be-
cause these two patients died without performing any follow
up MRI studies. The remaining 59 lesions were located as fol-
lows: 46 tumors were located supratentorially and 13 infraten-
torially with the most frequent location being in the parietal
lobe (11) pineal region (9), temporal lobe including the thala-mus (8) lateral ventricle (8), frontal lobe, frontal convexity
and frontopareital (6) supra and parasellar regions (3), occip-
ital lobe(1). The posterior fossa: tumors were located in the
brain stem (5), cerebellopontine angle (4) cerebellum (2), and
4th ventricle (2).
Group A included a total of 39 low grade tumors reported
as: 10 meningiomas, 4 shwanomas, 1 hemangiopericytoma, 1
cavernous angioma versus hemorrhagic glioma, 12 low grade
gliomas (including pilocytic astrocytoma, PXA and gangliogli-
oma), 4 low grade pineal region tumors (including germinima,
pineocytoma and astrocytoma), 1 DNET, 2 central neurocy-
toma, 1 ependymoma, 3 low grade subependymomas and 1
non neoplastic dormant lesion) e.g., Figs. 1 and 2.
Group B included 20 high grade neoplasms reported as: 6
high grade gliomas, 2 high grade pineal region tumors; germi-
nomas or pineocytomas, 1 anaplastic oligodendrogliojma, 10
metastases and 1 atypical meningioma e.g., Fig. 3.
No early complications or adverse reactions after radiosur-
gical treatment were identiﬁed in any case. In group A lesions:
Good tumor response was marked in 35 (89%) lesions (=true
negative), and local progression was marked in 4 (10%) lesions
(=false negative) of the present series. In group B: local pro-
gression deﬁned as tumor enlargement, local recurrence or
development of new lesions was marked in 13 (65%) lesions
(=true positive). Adequate tumor control for up to 24 months
was marked in 7 (35%) lesions (=false positive). Radiation-
induced tumor necrosis was diagnosed in 3 cases. The average
time interval between radiosurgical treatment and radiological
identiﬁcation of the local tumor recurrence constituted
8.7 ± 4.1 months (median: 9 months).
The values for normalized rCBV and metabolic contents of
the true negative (n = 35) and the true positive (n = 13) in the
present series were compared and are presented in Table 1.
Statistically signiﬁcant difference was found for the normalized
rCBV ratio between the low grade 0.97 (range 0.15–4.9) and
high grade tumors 2.35 (range 0.74–11.6) (p< 0.001). Signiﬁ-
cant median differences were also found for the Cho content as
a continuous variable between low-grade 1.1 (range 0.12 to
2.7) and high-grade tumors 1.92 (range 1–5.45) as shown by
the Mann–Whitney U test (P< 0.001). In 23 out of the 48 le-
sions the NAA values were close or equal to zero with signif-
icant differences between low (0.97; range 0.44 to 1.82) and
high grade tumors (0.32 range, 0.0 to 0.54). Therefore the
Chol/NAA ratio was not included among the considered
parameters. The metabolite ratio NAA/ Cr has shown more
statistically signiﬁcant differences between low (0.74 range
0.00–1.82) and high grade neoplasms (0.25 range 0.00–1.58)
than the normalized Chol/cr ratio. No or minimal lipids were
found in low grade tumors and, highly signiﬁcant median dif-
ferences in lipids are observed between low-grade (0.0; range
0.0 to 2.43) and high-grade (2.8; range, 0.6–10.4) tumors
(P< 0.001).
Correlation of the hemodynamic and metabolic characteris-
tics of the 59 lesions with local tumor control or progression
after radiosurgery has yielded a diagnostic accuracy for MR
perfusion and spectroscopy of 89% for low grade neoplasms,
65% for high grade neoplasms and 81% for both groups
(Table 2). The relatively low diagnostic accuracy among high
grade neoplasms is mostly attributed to possible overgrading
of some 3 gliomas that globally presented hemodynamic and
metabolic characteristics of low grade (WHO II) gliomas with
only some portions of the lesions showing criteria of high
Fig. 1 15-year-old male with an expanding well circumscribed pontine lesion extending cranially to the midbrain and caudally to the
medulla oblongata. (A) Unenhanced axial T1-weighted image demonstrates a hemorrhagic component along its posterior edge. (B) Axial
T2-weighted image shows increased signal intensity in the mass, with minimal peritumoral edema. (C–D) Gradient-echo axial perfusion
MR image with rCBV color overlay map shows low perfusion of the hemorrhagic part and increased perfusion around it with an rCBV
ratio of 2. (E) Post contrast axial, coronal and sagittal T1-weighted images demonstrate nodular enhancement around the hemorrhagic
component with non enhancing necrotic portions. (F) Spectrum from proton MR spectroscopy with the PRESS sequence demonstrates
markedly elevated Cho and decreased NAA with a pronounced increase of lipids and a lesser extent of lactate. Cho/cr ratio = 3.60 and
NAA/cr = 1.3. Combining the conventional, perfusion and spectroscopic data this mass was diagnosed as a diffuse (WHO grade III)
glioma.
Magnetic resonance spectroscopy and perfusion weighted imaging as predictors for tumor response 87grade (WHO III) gliomas, that corresponded to areas of
maximum enhancement in the post-contrast conventionalimages and areas of maximum rCBV in perfusion weighted
images.
Fig. 2 29 year old female patient, (A) Axial FLAIR image
demonstrates a heterogeneous left temporal subcortical lesion of
mixed signal suggesting solid and cystic components and slight
underlying calvarial remodeling. (B) Axial post-contrast TW
weighted image shows amarginal enhancement of the cystic portion,
and an enhancing solid component at the inferior aspect of the lesion
having a wide dural base (C), (D)Gradient-echo axial perfusionMR
image with rCBV color overlay map shows appreciable hyperper-
fusion denoted by elevated rCBV compared to contralateral white
matter with rCBV ratio = 3.8. (E) Spectrum from proton MR
spectroscopywith the PRESS sequence demonstrates amild increase
in Cho and decreasedNAAwith a Cho/cr ratio = 1 1.24 and NAA/
cr = 1. 21, There is a mild to moderate increase in lipid and lactate
with lipid increase could be artifactual due to close proximity to
calvarial fat. The spectroscopic and perfusion gradingwould put this
lesion as low grade .The close proximity tomeninges with meningeal
thickening more favors PXA than ganglioglioma.
Fig. 3 51 year old female. (A) Axial FLAIR weighted image
showing a small hyperintense intraventricular mass within the
anterior portion of the body of the right lateral ventricle with a
small extraventricular component. (B) Contrast-enhanced axial
T1-weighted image shows a small rounded enhancing nodule
within the hypointense intraventricular mass. (C, D) Gradient-
echo (1000/54) axial perfusion MR image with rCBV color overlay
map shows that the small enhancing nodule within the mass is
isoperfused to a normal white matter with an rCBV ratio = 0.7.
(E) Spectrum from proton MR spectroscopy with the PRESS
sequence demonstrates mildly elevated Cho and mild to moderate
decrease of NAA with a remarkable increase in myoinositol best
seen on the short echospectrum. Cho/cr ratio = 1.3, and NAA/
cr = 1.56 which is more in keeping with a low-grade neoplasm
subependymoma WHO I.
88 R.H. Bassiouny et al.4. Discussion
Radiosurgery is a noninvasive procedure where spatially accu-
rate and highly conformal doses of radiation are targeted atbrain lesions with an ablative intent. The therapeutic approach
depends on the imaging ﬁndings obtained prior to radiosur-
gery. To overcome limitations of the use of morphology-based
Table 1 Values for normalized rCBV and metabolic contents of the true negative and the true positive cases.
Metabolite True negative (35 low grade) True positive (13 high grade) P value
Normalized rCBV 0.97 (0.15–4.9) 2.35 (0.74–11.6) <0.001
Cho content 1.1 (range 0.12–2.7) 1.92 (range–5.45) <0.001
NAA content 0.97 (range 0.44–1.82) 0.22 (0.0–0.64) <0.005
Cho/cr 2.2 (0.89–3.4) 2.7 (0.00–5.8) <0.05
NAA/cr 0.74 (0.00–1.82) 0.25 (0.00–1.58) <0.005
Presence of lipid peak Absent in 20 and minimal in 15 Yes (n= 11)
No (n= 2)
Presence of lactate peak Absent in 30 Minimal in 5 Yes (n= 9)
No (n= 4)
Lipid content 0.00 (0.0–2.43) 2.8 (0.6–10.4) <0.001
Table 2 Diagnostic accuracy for MR perfusion and spectroscopy among low and high grade neoplasms.
MR diagnosis Complete control by radiosurgery Incomplete control with local progression Diagnostic accuracy (%)
Low grade (39) 35 (true negative) 4 (False negative) 89
High grade (20) 7 (false positive) 13 (True positive) 65
42 17 81
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tional MR imaging methods have been used, namely diffu-
sion-weighted imaging, perfusion MR imaging, and proton
MR spectroscopy. These imaging modalities provide addi-
tional information to allow clinicians to make proper decisions
regarding patient treatment. The metabolic, hemodynamic and
cellular alterations of brain tumors have known associations
with clinical predictors of tumor response to radiosurgery.
Therefore, it can be suspected that the metabolic proﬁle and
perfusion map of the neoplasm by itself might have some prog-
nostic signiﬁcance for the outcome after irradiation (7).
Several previous studies correlated mean rCBV values with
tumor grading histologically and angiographically. Sugahara
et al. (12) reported mean rCBV values of 7.32, 5.84, and 1.26
for glioblastomas, anaplastic astrocytomas, and low-grade gli-
omas, respectively. Aronen et al. (13) found mean maximal
rCBV values of 3.64 and 1.11 in high- and low-grade gliomas,
respectively (n= 19). Knopp et al. (14) had similar mean max-
imal rCBV values of 5.07 and 1.44 in high- and low-grade glio-
mas, respectively (n= 29). These values are close to those
reported by law et al. (15), with mean maximal rCBV values
of 5.18 and 2.14 for high- and low-grade gliomas, respectively.
Lev and Rosen (16) used an rCBV threshold value of 1.5 in dis-
criminating among 32 consecutive patients with glioma with a
reported sensitivity and speciﬁcity of 100% and 69%, respec-
tively. This compares with the results from the study by Law
et al. (15) of 95.0% and 57.5% sensitivity and speciﬁcity,
respectively, by using 1.75 as the threshold value. Zonari
et al. (3) reported a normalized perfusion threshold value in
the discrimination between low and high grade lesions > 1.16
(rCBV tumor /normal tissue ratio) with an estimated sensitivity
of 80% and speciﬁcity of 78.6%. More recently, Metellus et al.
(17) found that the mean rCBV values were signiﬁcantly differ-
ent between low- and high-grade gliomas, making it possible to
determine a threshold value of (2.5–3) that can separate these
two types of lesion. In accordance with these studies a threshold
value of 2 has been chosen to discriminate low and high grade
tumors in the present series. By retrospective veriﬁcation oftumor response to radiosurgery, those showing adequate
therapeutic control and assigned as low grade tumors have
shown a signiﬁcantly lower mean rCBV ratio (0.98) than those
exhibiting unfavorable therapeutic control and assigned as high
grade neoplasms (rCBV ratio = 2.8) (P< 0.0001).
Early in the development of MRS of brain tumors, a com-
monly asked question was whether or not MRS could help to
diagnose tumor type and grade non-invasively. Recent reports
supported the use of MRS as a powerful tool in tumor grading,
speciﬁcally, elevation in choline (Cho) and lipids with depres-
sion of N-acetylaspartate (NAA) and creatine. NAA decreases
as tumor growth displaces or destroys neurons. Very malig-
nant tumors have a high metabolic activity and deplete the en-
ergy stores, resulting in reduced creatine. Very hypercellular
tumors with rapid growth elevate the choline levels having a
higher membrane turnover. Lipids are found in necrotic por-
tions of tumors, and lactate appears when tumors outgrow
their blood supply and start utilizing anaerobic glycolysis.
Extensive literature has demonstrated the metabolite ratios
of Cho/creatine (Cr), NAA/Cr, and myo-inositol/Cr and the
presence of lipids and lactate to be powerful tools in grading
tumors and predicting tumor malignancy (18–21). However,
some studies have found high-grade tumors (e.g., grade IV
glioblastoma multiforme (GBM)) to have lower levels of
Cho than grade II or grade III astrocytoma (20). This may
be due to the presence of necrosis in high-grade tumors, partic-
ularly those with necrotic cores, since necrosis is associated
with low levels of all metabolites (23).
Using sophisticated analysis schemes and/or pattern recog-
nition techniques, several groups have been able to use proton
MR to accurately diagnose different types of neoplasia (25,26).
However, because of lesion variability, heterogeneity, overlap
between different tumor types, and also dependence on data
collection and analysis techniques, these results have proven
difﬁcult to replicate in general clinical practice. In most cases,
therefore, it is very difﬁcult for a clinician to use MRS alone to
diagnose the type of brain tumor with high conﬁdence. Rather,
MRS should perhaps be seen as an adjunct technique that may
90 R.H. Bassiouny et al.contribute to differential diagnoses that are being considered
on the basis of MRI, clinical and other information. For in-
stance, high Cho levels are typically seen in non-necrotic
high-grade brain tumors (for instance anaplastic astrocytoma,
GBM, primary CNS lymphoma), while necrotic GBM and
metastases are characterized by low levels of all metabolites
and increased lipids). Meningiomas are usually readily
diagnosed based on conventional imaging features, but the
diagnosis may be additionally conﬁrmed by the presence of a
signal from alanine (a doublet centered on 1.47 ppm), which
has been reported to be elevated in many meningiomas (27).
For discriminating solitary metastases from primary brain
tumors, it has been suggested that investigation of peri-
enhancing tumor regions may be useful; whereas gliomas are
often invasive lesions which show elevated Cho in surrounding
tissues, metastatic lesions tend to be more encapsulated and do
not typically show high Cho signals or other abnormalities
outside the region of enhancement (28,29).
In accordance with previous reports (4), our results con-
ﬁrmed that the Cho level is a useful parameter in determining
disease grade because it provides very high sensitivity values.
Statistically signiﬁcant median differences were found for the
Cho content, NAA content and lipid contents between tumors
assigned as low-grade and those assigned as high-grade based
on their response to radiosurgery (P< 0.001). Analyses of spec-
troscopy sampling based on Ch/cr and NAA/cr ratios in patho-
logic tissues have shown that the NAA/cr ratios were
signiﬁcantly lower in high grade than in low grade neoplasms
(P< 0.001). Such differences weremore signiﬁcant than the dif-
ferences in Ch/cr ratios between low and high grade tumors. The
low speciﬁcities for Cho/Cr that we and others (3–25) observed
were attributed to the high levels for Cho that were observed in
somemorphologically low-grade gliomas, This conﬁrms the low
correlation between the cellular level of the neoplasm, based on
Cho levels, and the grade of malignancy, deﬁned by atypical cel-
lular features, number ofmitoses, tumor neovascularization and
the presence of necrosis. Despite this low speciﬁcity, a signiﬁcant
difference was still noted in Cho/Cr between low- and high-
grade tumors (Table 1). The metabolite ratios reported in our
study are comparable to previously published data in differenti-
ating between low- and high-grade gliomas (5–34).
To date, there have been some efforts to combine perfusion
MR imaging and MR spectroscopic techniques in characteriz-
ing gliomas (30,31). Investigators have also combined these
two techniques to evaluate postoperative patients (32) or pedi-
atric patients with brain tumors (33). Only few previous studies
have investigated the utility of combining perfusion and MR
spectroscopy in predicting the outcome of radiosurgery in pri-
mary and secondary brain tumors. Chernov et al. (35) in their
study of 26 intracranial metastases which underwent metabolic
evaluation with single-voxel 1H-MRS before gamma Knife
radiosurgery, have found no signiﬁcant association of the
investigated 1H-MRS metabolic parameters with the outcome
after GKR. The negative results of this study made doubtful
the predictive value of metabolic characteristics of intracranial
metastases, detected with single-voxel 1H-MRS, for the out-
come after radiosurgery.
Graves et al. (9) attempted to investigate the use of proton
magnetic resonance spectroscopic imaging as a prognostic
indicator in gamma knife radiosurgery of 36 recurrent gliomas.
Patients were categorized on the basis of their initial spectro-
scopic results, and their performance was assessed in termsof change in contrast-enhancing volume, time to further treat-
ment, and survival. The trends in the overall population were
toward a more extensive increase in the percent of contrast-
enhancing volume, a decreased time to further treatment,
and a reduced survival time for patients with more extensive
initial metabolic abnormalities (i.e. signiﬁcantly elevated
choline and signiﬁcantly reduced NAA relative to the average
normal chol and NAA levels). Henry et al. (10) also attempted
to investigate the potential value of pre-external-beam radia-
tion therapy (XRT), apparent diffusion coefﬁcient (ADC) rel-
ative cerebral blood volume (rCBV) and cho/NAA index for
predicting survival in newly diagnosed patients with glioblas-
toma multiforme (GBM). He found that a signiﬁcantly shorter
median survival time was observed for patients with a large
volume of metabolic abnormality than for those with a small
abnormality (12.0 and 17.1 months, respectively, P= 0.002).
A similar pattern was observed for patients with a low mean
ADC value compared to those with a high mean nADC value
within the T2 region (11.2 and 21.7 months, respectively,
P= 0.004). They both recommended further studies to estab-
lish a statistical signiﬁcance for patients with lower-grade
lesions and to conﬁrm the results observed in their study.
In the present series of 59 intracranial neoplasms, we tried
to investigate the diagnostic utility of combining perfusion and
spectroscopic MR imaging with conventional MRI to predict
tumor grade and thereby the outcome of gamma knife radio-
surgery within an average of 2 years of follow up. We found
a signiﬁcant association between the pretherapeutic rCBV
and metabolite contents and ratios of the tumors and the out-
come of Gamma knife radiosurgery with an overall diagnostic
accuracy of the multimodel imaging mounting to 81%. Statis-
tically signiﬁcant differences (p< 0.001) were found in rCBV,
metabolite contents and ratios between typically low grade and
high grade malignant neoplasms.
Several limitations existed in this study: (1) lack of histopa-
thological diagnosis in the vast majority of the lesions as many
lesions were located at sites of high risk for biopsy (2) reliance
on previously reported threshold values for normalized rCBV
and Chol/cr and NAA/ cr ratios for discriminating benign
from low grade malignancies (3) the diversity of investigated
tumor types including morphologically benign, low and high
grade malignant neoplasms. (4) the relatively low diagnostic
accuracy of multimodel MRI among high grade neoplasms
that was most probably attributed to overgrading of some
low grade into high grade malignant neoplasms due to hetero-
geneity of the lesions.References
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